Jean has made over 2 trades of the Kaleido Biosciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 18,196 units of KLDO stock worth $247,466 on 12 September 2017.
The largest trade she's ever made was exercising 18,196 units of Kaleido Biosciences Inc stock on 12 September 2017 worth over $247,466. On average, Jean trades about 4,254 units every 43 days since 2016. As of 12 September 2017 she still owns at least 24,901 units of Kaleido Biosciences Inc stock.
You can see the complete history of Ms. Mixer stock trades at the bottom of the page.
Jean K. Mixer serves as Independent Director of the Company. Ms. Mixer is the Chief Digital Transformation Officer and Vice President of Strategy at Boston Children’s Hospital, which she joined in January 2014. From 2005 to January 2014, she served as Chief Executive Officer of mixerconsulting, which has helped organizations grow through strategic and organizational work. From 1992 to 2004, she was at the Boston Consulting Group, where she was partner in the Boston office. Before that, Ms. Mixer was an officer at J.P. Morgan in New York. From 2006 to February 2019, Ms. Mixer was a director on the board of NxStage Medical, Inc. where she served on the audit and compensation committees. From 2006 to January 2014, Ms. Mixer was a director on the board of the Cambridge Trust Company, a commercial bank, where she also served as a member of the board’s executive committee and chair of its compensation committee. She is also an overseer at the Boys and Girls Clubs of Boston. Formerly, she served on the Business Roundtable Committee on National Health Care Reform. She has worked broadly across the restructuring healthcare market, including providers, payers, pharmaceuticals, medical devices, pharmacies and pharmacy benefit managers.
As the Independent Director of Kaleido Biosciences Inc, the total compensation of Jean Mixer at Kaleido Biosciences Inc is $531,179. There are 4 executives at Kaleido Biosciences Inc getting paid more, with Jerald Korn having the highest compensation of $1,505,420.
Jean Mixer is 53, she's been the Independent Director of Kaleido Biosciences Inc since 2019. There are 9 older and 8 younger executives at Kaleido Biosciences Inc. The oldest executive at Kaleido Biosciences Inc is Anne Prener, 62, who is the Independent Director.
Jean's mailing address filed with the SEC is C/O KALEIDO BIOSCIENCES, INC., 65 HAYDEN AVENUE, LEXINGTON, MA, 02421.
Over the last 6 years, insiders at Kaleido Biosciences Inc have traded over $0 worth of Kaleido Biosciences Inc stock and bought 3,273,186 units worth $32,952,342 . The most active insiders traders include Ventures Fund Iv General Pa..., Joshua T Brumm y Ventures Fund V General Par.... On average, Kaleido Biosciences Inc executives and independent directors trade stock every 119 days with the average trade being worth of $55. The most recent stock trade was executed by Daniel L Menichella on 8 February 2021, trading 20,000 units of KLDO stock currently worth $230,000.
the next breakthrough microbiome company from flagship venturelabs – the innovation foundry of flagship ventures – is coming.
Kaleido Biosciences Inc executives and other stock owners filed with the SEC include: